| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/DMRR.728 |
| P698 | PubMed publication ID | 17315136 |
| P50 | author | Rachel Dankner | Q42845391 |
| Angela Chetrit | Q47460871 | ||
| P2093 | author name string | Itamar Raz | |
| Julio Wainstein | |||
| Yariv Gerber | |||
| Muhammad A Abdul-Ghani | |||
| P2860 | cites work | Risk for diabetes and persistent impaired glucose tolerance among middle-aged Finns. | Q51580114 |
| The natural history of impaired glucose tolerance in the Pima Indians. | Q51623599 | ||
| Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group | Q66972631 | ||
| Significance of impaired glucose tolerance in an Asian Indian population: a follow-up study | Q68894628 | ||
| Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects | Q93735851 | ||
| Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 | ||
| Hyperinsulinemia. A link between hypertension obesity and glucose intolerance | Q24564030 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
| Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study | Q29615122 | ||
| Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Impaired fasting glucose and impaired glucose tolerance - lack of agreement between the two categories in a North Indian population | Q31880003 | ||
| Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial | Q33425402 | ||
| Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? | Q34111683 | ||
| Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention | Q34808433 | ||
| Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies | Q36839519 | ||
| Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections | Q39474763 | ||
| Undiagnosed diabetes and impaired glucose regulation in adult Ghanaians using the ADA and WHO diagnostic criteria | Q39604429 | ||
| The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward? | Q40553813 | ||
| Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? | Q40819765 | ||
| Relative role of insulin resistance and beta-cell dysfunction in the progression to type 2 diabetes--The Kinmen Study | Q42437184 | ||
| Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study | Q43580702 | ||
| Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study | Q43935522 | ||
| Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women | Q44114894 | ||
| Identifying the target population for primary prevention: the trade-offs | Q44195353 | ||
| Coffee consumption and risk of type 2 diabetes mellitus | Q44217673 | ||
| Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study | Q44286396 | ||
| Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans | Q44333514 | ||
| Lowering the criterion for impaired fasting glucose will not provide clinical benefit | Q44666295 | ||
| Lowering the criterion for impaired fasting glucose is in order | Q44666297 | ||
| Mode of onset of type 2 diabetes from normal or impaired glucose tolerance | Q44704987 | ||
| beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis | Q45105931 | ||
| Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM. | Q46729883 | ||
| Normal fasting plasma glucose levels and type 2 diabetes in young men. | Q46738240 | ||
| Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes | Q47883653 | ||
| Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study | Q50546299 | ||
| The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. | Q51554484 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 551-558 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
| P1476 | title | Predicting the 20-year diabetes incidence rate. | |
| P478 | volume | 23 |
| Q24647005 | Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report |
| Q51366399 | Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx ® Diabetes Risk Score. |
| Q39416214 | Comparison of normal fasting and one-hour glucose levels as predictors of future diabetes during a 34-year follow-up. |
| Q58102155 | Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia |
| Q35696511 | Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance |
| Q43932153 | Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). |
| Q36996564 | Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth |
| Q49822604 | Lessons learned from the 1-hour post-load glucose level during the OGTT - Current screening recommendations for dysglycemia should be revised |
| Q37130144 | Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? |
| Q33610774 | Plasma glucose concentration and prediction of future risk of type 2 diabetes |
| Q37777010 | Prediabetes: The Importance of Early Identification and Intervention |
| Q37207156 | Predictive Value of Glucose Parameters Obtained From Oral Glucose Tolerance Tests in Identifying Individuals at High Risk for the Development of Diabetes in Korean Population |
| Q37028898 | Predictive models for type 2 diabetes onset in middle-aged subjects with the metabolic syndrome |
| Q37163724 | Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program |
| Q57478230 | The Impact of the Hazard Correlation between Risk Factors and Diabetes |
| Q37660219 | Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus |
| Q35179935 | Two-step approach for the prediction of future type 2 diabetes risk |
| Q38241464 | What are the pharmacotherapy options for treating prediabetes? |
Search more.